Improving T2DM Detection Using Spot cHbA1c Test

NACompletedINTERVENTIONAL
Enrollment

852

Participants

Timeline

Start Date

June 11, 2022

Primary Completion Date

December 12, 2023

Study Completion Date

December 12, 2023

Conditions
Diabetes MellitusPre-diabetes
Interventions
PROCEDURE

POC-cHbA1c testing

The point-of-care HbA1c instrument employed in this study will be the Cobas b 101 (Roche Diagnostics, Switzerland) diagnostic test system. A capillary blood sample will be obtained by dermal puncture of a fingertip using a disposable lancet and resorbed in the specially marked area of the Cobas b 101 test disc. The disc will be inserted in the autoanalyzer. Test results displayed in both % and mmol/l will be available within 10 minutes.

Trial Locations (8)

Unknown

Aberdeen Jockey Club General Out-Patient Clinic, Hong Kong

Kwun Tong Community Health Centre, Hong Kong

Lek Yuen General Out-Patient Clinic, Hong Kong

Li Po Chun General Out-Patient Clinic, Hong Kong

Ma On Shan Family Medicine Centre, Hong Kong

Sai Ying Pun Jockey Club General Out-patient Clinic, Hong Kong

Tseung Kwan O (Po Ning Road) General Out-patient Clinic, Hong Kong

Yau Ma Tei Jockey Club Specialist Clinic, Hong Kong

All Listed Sponsors
collaborator

Hospital Authority, Hong Kong

OTHER_GOV

collaborator

Food and Health Bureau, Hong Kong

OTHER_GOV

lead

The University of Hong Kong

OTHER